Clinical Trials Directory

Trials / Completed

CompletedNCT00066027

Effects of Low-Dose Doxycycline on Oral Bone Loss

Low-Dose Doxycycline Effects on Osteopenic Bone Loss

Status
Completed
Phase
Phase 3
Study type
Interventional
Enrollment
128 (actual)
Sponsor
University of Nebraska · Academic / Other
Sex
Female
Age
45 Years – 70 Years
Healthy volunteers
Not accepted

Summary

The primary purpose of this clinical trial is to determine whether low-dose doxycycline can reduce alveolar bone density loss in postmenopausal osteopenic women with periodontitis and not on hormone replacement therapy (i.e., estrogen deficient).

Detailed description

The primary purpose of this clinical trial is to determine whether low-dose doxycycline (LDD) can reduce alveolar bone density loss in postmenopausal osteopenic women with periodontitis and not on hormone replacement therapy (i.e., estrogen deficient). The effects of LDD on alveolar bone height loss, progressive periodontal attachment loss, systemic bone mineral density, gingival crevicular fluid biochemical markers of collagen degradation and bone resorption and serum biomarkers of bone formation, bone resorption and inflammation also will be assessed. In addition, another objective is to determine if the microbial effects obtained with LDD over two years are equivalent to a placebo control. This clinical trial involves two clinical sites: the University of Nebraska Medical Center College of Dentistry and Stony Brook University School of Dental Medicine. A total of 128 postmenopausal osteopenic women with periodontitis between the ages of 45 and 70 at the time of telephone screening will be randomized to LDD or placebo groups and subjects will be followed for two years.

Conditions

Interventions

TypeNameDescription
DRUG20 mg doxycycline hyclateSubjects in the LDD group took 20 mg doxycycline hyclate tablets twice daily for two years
DRUGPlaceboSubjects in the placebo group took a placebo look-alike twice daily for two years.

Timeline

Start date
2002-06-01
Primary completion
2005-10-01
Completion
2005-10-01
First posted
2003-08-05
Last updated
2023-09-06

Locations

2 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT00066027. Inclusion in this directory is not an endorsement.